Author

Günter Schneider 1

1 Technische Universität München, Klinikum rech

A DRUG REPURPOSING APPROACH TO INHIBIT AMPK IN CONTEXT OF PANCREATIC DUCTAL ADENOCARCINOMA

Franziska Génevaux, Carolin Schneider, Christian Schneeweis, Zonera Hassan, Svenja Lier, Felix Orben, Roland Rad, Maximilian Reichert, Dieter Saur, Günter Schneider

CLASS I HISTONE DEACETYLASE INHIBITORS CONTROL THE MYC NETWORK IN PANCREATIC DUCTAL ADENOCARCINOMA

Markus Rösch, Christian Schneeweis, Zonera Hassan, Maximilian Reichert, Günter Schneider

HDACs and HDAC inhibitors in pancreatic cancer

Günter Schneider

IEX-1 KNOCKOUT IN AN EX VIVO MOUSE MODEL OF PANCREATIC CANCER INHIBITS DNA DAMAGE INDUCED NF-KAPPAB ACTIVITY AND MCL-1 NUCLEAR TRANSLOCATION LEADING TO ENHANCED APOPTOSIS

Claudia Geismann, Matthias Wirth, Antje Weber, Kim Waldenberg, Frauke Grohmann, Philip Rosenstiel, Stefan Schreiber, Dieter Saur, Heiner Schäfer, Günter Schneider

INTERSTITIAL CELLS OF CAJAL INTEGRATE EXCITATORY AND INHIBITORY NEUROTRANSMISSION WITH INTESTINAL SLOW WAVE ACTIVITY

Sabine Klein, Barbara Seidler, Anna Kettenberger, Andrei Sibaev, Michael Schemann, Günter Schneider, Dieter Saur, Martin A. Storr, Roland M. Schmid

NEXT GENERATION MOUSE MODELS FOR SEQUENTIAL AND HOST SPECIFIC GENETIC MANIPULATION OF PANCREATIC CANCER

Nina Reiff, Barbara Seidler, Kathleen Gottschalk, Roland Rad, Günter Schneider, Dieter Saur, Roland M. Schmid

SCREENING OF A DRUG-LIBRARY IN HDAC-2 PROFICIENT AND DEFICIENT MURINE PANCREATIC DUCTAL ADENOCARCINOMA CELLS TO IDENTIFY NEW POTENTIAL COMBINATION THERAPIES

Lukas Krauß, Marc Kidess, Günter Schneider

SNAIL BYPASSES SENESCENCE AND ACCELERATES TUMOR PROGRESSION IN A KRAS-DRIVEN MOUSE MODEL OF PANCREATIC CANCER

Mariel C. Paul, Benjamin Walter, Barbara Seidler, Angelika Schnieke, Günter Schneider, Dieter Saur, Roland M. Schmid

Item 1 - 8 / 9
1